Reviewing Hero Technologies (OTCMKTS:HENC) and Veru (NASDAQ:VERU)

Hero Technologies (OTCMKTS:HENC) and Veru (NASDAQ:VERU) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership.

Valuation & Earnings

This table compares Hero Technologies and Veru”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hero Technologies	N/A	N/A	N/A	N/A	N/A
Veru	$16.89 million	2.31	-$22.73 million	($1.26)	-1.93

Hero Technologies has higher earnings, but lower revenue than Veru.

Volatility & Risk

Hero Technologies has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500. Comparatively, Veru has a beta of -1.35, suggesting that its share price is 235% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Hero Technologies and Veru, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hero Technologies	0	0	0	0	0.00
Veru	1	0	3	0	2.50

Veru has a consensus target price of $22.50, indicating a potential upside of 825.93%. Given Veru’s stronger consensus rating and higher possible upside, analysts plainly believe Veru is more favorable than Hero Technologies.

Institutional & Insider Ownership

47.2% of Veru shares are owned by institutional investors. 0.2% of Hero Technologies shares are owned by insiders. Comparatively, 14.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Hero Technologies and Veru’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hero Technologies	N/A	N/A	N/A
Veru	N/A	-83.63%	-55.90%

Summary

Veru beats Hero Technologies on 6 of the 9 factors compared between the two stocks.

About Hero Technologies

Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company is based in Dover, Delaware.

About Veru

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company’s development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.